These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 33234263)

  • 1. Experimental agents to improve fracture healing: utilizing the WNT signaling pathway.
    Haffner-Luntzer M
    Injury; 2021 Jun; 52 Suppl 2():S44-S48. PubMed ID: 33234263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Wnt serpentine receptor Frizzled-9 regulates new bone formation in fracture healing.
    Heilmann A; Schinke T; Bindl R; Wehner T; Rapp A; Haffner-Luntzer M; Nemitz C; Liedert A; Amling M; Ignatius A
    PLoS One; 2013; 8(12):e84232. PubMed ID: 24391920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic administration of pharmacological agents and bone repair: what can we expect.
    Bukata SV
    Injury; 2011 Jun; 42(6):605-8. PubMed ID: 21507402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hematopoietic Wnts Modulate Endochondral Ossification During Fracture Healing.
    Chua K; Lee VK; Chan C; Yew A; Yeo E; Virshup DM
    Front Endocrinol (Lausanne); 2021; 12():667480. PubMed ID: 34108937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Wnt modulation in bone healing.
    Schupbach D; Comeau-Gauthier M; Harvey E; Merle G
    Bone; 2020 Sep; 138():115491. PubMed ID: 32569871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antagonizing midkine accelerates fracture healing in mice by enhanced bone formation in the fracture callus.
    Haffner-Luntzer M; Heilmann A; Rapp AE; Roessler R; Schinke T; Amling M; Ignatius A; Liedert A
    Br J Pharmacol; 2016 Jul; 173(14):2237-49. PubMed ID: 27111560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anabolic Strategies to Augment Bone Fracture Healing.
    Roberts SJ; Ke HZ
    Curr Osteoporos Rep; 2018 Jun; 16(3):289-298. PubMed ID: 29725836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apigenin promotes osteogenic differentiation of mesenchymal stem cells and accelerates bone fracture healing via activating Wnt/β-catenin signaling.
    Pan FF; Shao J; Shi CJ; Li ZP; Fu WM; Zhang JF
    Am J Physiol Endocrinol Metab; 2021 Apr; 320(4):E760-E771. PubMed ID: 33645251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sclerostin Neutralizing Antibody Treatment Enhances Bone Formation but Does Not Rescue Mechanically Induced Delayed Healing.
    Kruck B; Zimmermann EA; Damerow S; Figge C; Julien C; Wulsten D; Thiele T; Martin M; Hamdy R; Reumann MK; Duda GN; Checa S; Willie BM
    J Bone Miner Res; 2018 Sep; 33(9):1686-1697. PubMed ID: 29694687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sclerostin Antibody Increases Callus Size and Strength but does not Improve Fracture Union in a Challenged Open Rat Fracture Model.
    Morse A; McDonald MM; Schindeler A; Peacock L; Mikulec K; Cheng TL; Liu M; Ke HZ; Little DG
    Calcif Tissue Int; 2017 Aug; 101(2):217-228. PubMed ID: 28391431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fracture repair: general aspects and influence of osteoporosis and anti-osteoporosis treatment.
    Féron JM; Mauprivez R
    Injury; 2016 Jan; 47 Suppl 1():S10-4. PubMed ID: 26768282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Wnt1 Boosts Fracture Healing by Enhancing Bone Formation in the Fracture Callus.
    Haffner-Luntzer M; Ragipoglu D; Ahmad M; Schoppa A; Steppe L; Fischer V; Luther J; Yorgan T; Bockamp E; Amling M; Schinke T; Ignatius A
    J Bone Miner Res; 2023 May; 38(5):749-764. PubMed ID: 36891752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sclerostin antibody treatment improves fracture outcomes in a Type I diabetic mouse model.
    Yee CS; Xie L; Hatsell S; Hum N; Murugesh D; Economides AN; Loots GG; Collette NM
    Bone; 2016 Jan; 82():122-34. PubMed ID: 25952969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implications for fracture healing of current and new osteoporosis treatments: an ESCEO consensus paper.
    Goldhahn J; Féron JM; Kanis J; Papapoulos S; Reginster JY; Rizzoli R; Dere W; Mitlak B; Tsouderos Y; Boonen S
    Calcif Tissue Int; 2012 May; 90(5):343-53. PubMed ID: 22451221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-sclerostin - is there an indication?
    Larsson S
    Injury; 2016 Jan; 47 Suppl 1():S31-5. PubMed ID: 26768288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential role of bone morphogenetic proteins in fracture healing.
    Bostrom MP; Camacho NP
    Clin Orthop Relat Res; 1998 Oct; (355 Suppl):S274-82. PubMed ID: 9917647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wnt signaling in bone formation and its therapeutic potential for bone diseases.
    Kim JH; Liu X; Wang J; Chen X; Zhang H; Kim SH; Cui J; Li R; Zhang W; Kong Y; Zhang J; Shui W; Lamplot J; Rogers MR; Zhao C; Wang N; Rajan P; Tomal J; Statz J; Wu N; Luu HH; Haydon RC; He TC
    Ther Adv Musculoskelet Dis; 2013 Feb; 5(1):13-31. PubMed ID: 23514963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibroblast growth factor-2, bone homeostasis and fracture repair.
    Fei Y; Gronowicz G; Hurley MM
    Curr Pharm Des; 2013; 19(19):3354-63. PubMed ID: 23432676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta-catenin signaling plays a disparate role in different phases of fracture repair: implications for therapy to improve bone healing.
    Chen Y; Whetstone HC; Lin AC; Nadesan P; Wei Q; Poon R; Alman BA
    PLoS Med; 2007 Jul; 4(7):e249. PubMed ID: 17676991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta-catenin in the race to fracture repair: in it to Wnt.
    Silkstone D; Hong H; Alman BA
    Nat Clin Pract Rheumatol; 2008 Aug; 4(8):413-9. PubMed ID: 18560386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.